Alligator Bioscience AB (0RK9) AI Stock Analysis

Alligator Bioscience AB

(LSE:0RK9)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Cancer Immunotherapy FocusA focused oncology strategy gives Alligator a clear scientific identity in a large therapeutic area. Its antibody-based approach targets immune mechanisms rather than a single narrow disease, which may support multiple development opportunities if clinical evidence validates the platform.

Negative Factors

Persistent UnprofitabilityThe company remains far from self-funded profitability, with losses vastly exceeding reported revenue and negative gross profit. This limits internal financing capacity and means future progress will likely depend on additional funding, successful partnerships, or meaningful improvement in commercial outcomes.

Alligator Bioscience AB (0RK9) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: SEK 35.32M
Dividend Yield: ―
Average Volume (3M): 245.79K
Price to Earnings (P/E): -0.0
Beta (1Y): 0.51
Revenue Growth: -99.33%
EPS Growth: 64.90%
Country: UK
Employees: 11
Sector: General
Sector Strength: 55
Industry: Biotechnology

Alligator Bioscience AB Business Overview & Revenue Model

Company Description

Alligator Bioscience AB (publ) is a research-intensive biotechnology company based in Lund, Sweden, focused on developing innovative antibody-based treatments for cancer. The company leverages several proprietary technology platforms to drive its dru...

Alligator Bioscience AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

GB:0RK9 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CANTA	70Outperform	SEK 451.68M	2.35	63.09%	―	―	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
SE:ELIC	48Neutral	SEK 177.19M	-7.51	-56.09%	―	―	14.10%
SE:ONCO	47Neutral	SEK 721.66M	-2.14	―	―	87.23%	35.27%
SE:BINV	43Neutral	SEK 357.32M	-0.73	-128.54%	―	-83.67%	-50.29%
SE:IMMU	43Neutral	SEK 348.89M	-3.07	-18.05%	―	―	15.97%

* General Sector Average

Performance Comparison

GB:0RK9 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0RK9	Alligator Bioscience AB	0.01	-0.35	-96.69%
SE:BINV	BioInvent International AB	5.43	-28.47	-83.98%
SE:ONCO	Oncopeptides AB	1.67	-3.75	-69.16%
SE:ELIC	Elicera Therapeutics AB	2.65	-3.44	-56.47%
SE:IMMU	Immunicum AB	5.50	-1.89	-25.58%
SE:CANTA	Cantargia AB	1.60	-1.97	-55.13%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Alligator Bioscience AB AI Stock Analysis